TipRanks
Beijing Tong Ren Tang Chinese Medicine Co Ltd (BJTRF)
OTHER OTC:BJTRF
US Market
BJTRF
Beijing Tong Ren Tang Chinese Medicine Co
RESEARCH TOOLSreports

Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) Ratios

8 Followers

Beijing Tong Ren Tang Chinese Medicine Co Ratios

BJTRF's free cash flow for Q2 2026 was HK$0.64. For the 2026 fiscal year, BJTRF's free cash flow was decreased by HK$ and operating cash flow was HK$0.36. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 21.03 19.65 16.85 11.65 8.80
Quick Ratio
 14.30 13.16 10.10 8.59 7.68
Cash Ratio
 11.58 10.77 7.53 3.03 4.76
Solvency Ratio
 1.92 1.43 1.88 1.51 1.48
Operating Cash Flow Ratio
 5.21 4.20 -0.92 1.40 1.31
Short-Term Operating Cash Flow Coverage
 19.30 12.23K -3.06K 2.78K 2.50K
Net Current Asset Value
HK$ 3.65BHK$ 3.77BHK$ 3.65BHK$ 3.43BHK$ 3.20B
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 0.03 0.02
Debt-to-Equity Ratio
 0.03 0.03 0.03 0.03 0.03
Debt-to-Capital Ratio
 0.03 0.03 0.03 0.03 0.03
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Financial Leverage Ratio
 1.11 1.11 1.12 1.15 1.17
Debt Service Coverage Ratio
 9.14 71.14 94.89 111.06 158.39
Interest Coverage Ratio
 101.01 83.43 89.02 104.41 174.12
Debt to Market Cap
 0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.16 0.16 0.16 0.16 0.13
Net Debt to EBITDA
 -3.39 -4.24 -2.28 -1.11 -2.08
Profitability Margins
Gross Profit Margin
62.83%61.16%66.10%68.67%66.44%
EBIT Margin
32.47%31.45%39.48%45.49%47.98%
EBITDA Margin
36.28%32.74%44.82%51.12%52.43%
Operating Profit Margin
32.25%31.20%35.80%40.93%46.88%
Pretax Profit Margin
34.16%33.35%39.08%45.10%47.71%
Net Profit Margin
27.78%26.25%31.04%35.44%37.31%
Continuous Operations Profit Margin
28.57%27.55%32.83%38.73%40.02%
Net Income Per EBT
81.33%78.71%79.44%78.57%78.20%
EBT Per EBIT
105.93%106.87%109.16%110.20%101.77%
Return on Assets (ROA)
10.19%8.52%10.97%12.19%15.29%
Return on Equity (ROE)
11.15%9.48%12.28%13.98%17.92%
Return on Capital Employed (ROCE)
12.34%10.60%13.34%15.21%21.32%
Return on Invested Capital (ROIC)
10.20%8.66%11.06%12.88%17.65%
Return on Tangible Assets
10.34%8.64%11.14%12.34%15.51%
Earnings Yield
9.40%5.61%6.81%5.25%6.73%
Efficiency Ratios
Receivables Turnover
 3.82 3.62 3.06 3.61 1.84
Payables Turnover
 16.65 9.48 14.25 2.70 3.78
Inventory Turnover
 0.49 0.44 0.34 0.47 1.24
Fixed Asset Turnover
 3.73 3.36 3.91 3.49 4.27
Asset Turnover
 0.37 0.32 0.35 0.34 0.41
Working Capital Turnover Ratio
 0.44 0.40 0.44 0.45 0.55
Cash Conversion Cycle
 818.28 895.31 1.16K 739.00 397.20
Days of Sales Outstanding
 95.66 100.71 119.13 101.24 198.62
Days of Inventory Outstanding
 744.55 833.13 1.06K 772.98 295.15
Days of Payables Outstanding
 21.92 38.52 25.62 135.22 96.57
Operating Cycle
 840.20 933.83 1.18K 874.22 493.77
Cash Flow Ratios
Operating Cash Flow Per Share
 1.16 1.04 -0.26 0.55 0.65
Free Cash Flow Per Share
 1.11 0.99 -0.31 0.52 0.61
CapEx Per Share
 0.05 0.05 0.05 0.03 0.05
Free Cash Flow to Operating Cash Flow
 0.96 0.95 1.20 0.95 0.93
Dividend Paid and CapEx Coverage Ratio
 1.79 2.60 -0.68 1.55 1.14
Capital Expenditure Coverage Ratio
 23.59 21.08 -5.03 21.08 14.22
Operating Cash Flow Coverage Ratio
 7.71 6.86 -1.76 3.50 5.31
Operating Cash Flow to Sales Ratio
 0.59 0.57 -0.13 0.30 0.32
Free Cash Flow Yield
19.00%11.68%-3.54%4.26%5.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.54 18.00 14.69 19.05 14.85
Price-to-Sales (P/S) Ratio
 2.95 4.68 4.56 6.75 5.54
Price-to-Book (P/B) Ratio
 1.21 1.69 1.80 2.66 2.66
Price-to-Free Cash Flow (P/FCF) Ratio
 5.26 8.56 -28.22 23.46 18.85
Price-to-Operating Cash Flow Ratio
 5.04 8.16 -33.83 22.34 17.52
Price-to-Earnings Growth (PEG) Ratio
 -0.93 -0.83 -1.91 -1.22 2.71
Price-to-Fair Value
 1.21 1.69 1.80 2.66 2.66
Enterprise Value Multiple
 4.76 10.05 7.89 12.09 8.49
Enterprise Value
 2.86B 4.98B 5.70B 9.43B 7.71B
EV to EBITDA
 4.76 10.05 7.89 12.09 8.49
EV to Sales
 1.73 3.29 3.54 6.18 4.45
EV to Free Cash Flow
 3.07 6.02 -21.89 21.48 15.14
EV to Operating Cash Flow
 2.94 5.74 -26.24 20.46 14.08
Tangible Book Value Per Share
 4.99 5.14 4.99 4.74 4.40
Shareholders’ Equity Per Share
 4.84 5.00 4.87 4.62 4.31
Tax and Other Ratios
Effective Tax Rate
 0.16 0.17 0.16 0.14 0.16
Revenue Per Share
 1.98 1.81 1.93 1.82 2.07
Net Income Per Share
 0.55 0.47 0.60 0.65 0.77
Tax Burden
 0.81 0.79 0.79 0.79 0.78
Interest Burden
 1.05 1.06 0.99 0.99 0.99
Research & Development to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
 0.30 0.26 0.31 0.12 0.09
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.79 2.19 -0.34 0.85 0.66
Currency in HKD